SCHEMBL2979421

SCHEMBL2979421

CN(Cc1cccn1C)C1CCCCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 2/20 0.50
HRH4 Q9H3N8 1/20 0.50
HSD11B1 P28845 2/20 0.44
CYP3A4 P08684 2/20 0.44
ALDH1A1 P00352 4/20 0.43
LMNA P02545 2/20 0.43
MAPT P10636 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
KDM4E B2RXH2 2/20 0.41
LTA4H P09960 1/20 0.39
ABCB11 O95342 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
AR P10275 1/20 0.38
CYP2D6 P10635 1/20 0.38
SLC6A2 P23975 1/20 0.38
PDE4A P27815 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38
KCNH2 Q12809 1/20 0.38
SIGMAR1 Q99720 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7603670 0.70 HRH3 (0.73) HRH3HRH4ALDH1A1LMNAMAPT
Hydrochloric Acid SCHEMBL9393545 0.69 HRH3 (0.71) HRH3HRH4ALDH1A1LMNAMAPT
SCHEMBL531089 0.68 HRH3 (0.70) HRH3HRH4ALDH1A1LMNAMAPT
SCHEMBL8250796 0.67 KDM4E (0.52) HRH3HSD11B1CYP3A4ALDH1A1LMNA
SCHEMBL2979417 0.67 KMT2A (0.56) HSD11B1CYP3A4ALDH1A1MAPTSMN1; SMN2
SCHEMBL11251947 0.66 HRH3 (0.67) HRH3HRH4ALDH1A1LMNAMAPT
SCHEMBL3973791 0.66 TRPM8 (0.44) HRH3HSD11B1CYP3A4ALDH1A1MAPT
SCHEMBL12082363 0.66 HRH3 (0.77) HRH3HRH4ALDH1A1LMNAMAPT
SCHEMBL24158294 0.66 HRH3 (0.65) HRH3HRH4ALDH1A1LMNAMAPT
SCHEMBL365219 0.66 ALDH1A1 (0.55) HRH3HRH4CYP3A4ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776903-B2 Pharmaceutical preparations containing substituted 2,5-diaminomethyl-1H-pyrroles GRUENENTHAL GMBH (DE) 2010-08-17 US disclosed
EP-1578416-B1 MEDICAMENTS CONTAINING SUBSTITUTED 2,5-DIAMINOMETHYL-1H-PYRROLES GRUENENTHAL GMBH (DE) 2006-08-02 EP disclosed
US-20050272782-A1 Pharmaceutical preparations containing substituted 2,5-diaminomethyl-1H-pyrroles GRUENENTHAL GMBH (DE) 2005-12-08 US disclosed
EP-1578416-A1 MEDICAMENTS CONTAINING SUBSTITUTED 2,5-DIAMINOMETHYL-1H-PYRROLES Grünenthal GmbH (DE) 2005-09-28 EP disclosed
WO-2004058248-A1 MEDICAMENTS CONTAINING SUBSTITUTED 2,5-DIAMINOMETHYL-1H-PYRROLES Grünenthal GmbH (DE) 2004-07-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050272782-A1 Pharmaceutical preparations containing substituted 2,5-diaminomethyl-1H-pyrroles THPO, ADCYAP1R1, DPYD HRH3 1443/4885HRH4 396/4885HSD11B1 2883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.